Evidence map›Paper›PMID 31231218›Full record

ArticleFrontiers in pharmacology2019

The Protective Effect of Magnesium Lithospermate B on Hepatic Ischemia/Reperfusion

Ning Zhang, Li Han, Yaru Xue, Qiangqiang Deng, Zhitao Wu, Huige Peng, Yiting Zhang, Lijiang Xuan, Guoyu Pan, Qiang Fu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Magnesium in renal fibrosis.International urology and nephrology · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Gigantol ameliorates CClScientific reports · 2020
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ning ZhangDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China.
Li HanShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Yaru XueShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Qiangqiang DengShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Zhitao WuShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Huige PengShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Yiting ZhangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Lijiang XuanShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Guoyu PanShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Qiang FuDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China.
Chinese Academy of Sciences · CNShanghai Institute of Materia Medica · CNChina Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute inflammation is an important component of the pathogenesis of hepatic ischemia/reperfusion injury (HIRI). Magnesium lithospermate B (MLB) has strong neuroprotective and cardioprotective effects. The purpose of this study was to determine whether MLB had underlying protective effects against hepatic I/R injury and to reveal the potential mechanisms related to the hepatoprotective effects. In this study, we first examined the protective effect of MLB on HIRI in mice that underwent 1 h ischemia followed by 6 h reperfusion. MLB pretreatment alleviated the abnormal liver function and hepatocyte damage induced by I/R injury. We found that serum inflammatory cytokines, including IL-6, IL-1β, and TNF-α, were significantly decreased by MLB during hepatic ischemia/reperfusion (I/R) injury, suggesting that MLB may alleviate hepatic I/R injury

Indexed as

acute injuryanti-inflammationhepatic ischemia/reperfusionJak2/Stat3 signaling pathwaymagnesium lithospermate B

Identifiers

PMID31231218
PMCPMC6558428
OpenAlexW2947871222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.